​
Login / Signup
Anbok Lee
ORCID
Publication Activity (10 Years)
Years Active: 2019-2022
Publications (10 Years): 7
Top Topics
Breast Cancer Risk
Capillary Electrophoresis
Sentinel Lymph Node
Neoadjuvant Chemotherapy
Top Venues
Taehan Yongsang Uihakhoe chi
Journal of Korean medical science
PloS one
Annals of laboratory medicine
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Anbok Lee
,
Hee Yeon Kim
,
Tae Hyun Kim
,
Ki Jung Ahn
,
Heunglae Cho
,
Sung Kwang Park
,
Yunseon Choi
Hypofractionated Radiotherapy for Early-Stage Breast Cancer: A Propensity Score Matched Analysis.
Journal of Korean medical science
37 (8) (2022)
Ga Young Lee
,
Gi Won Shin
,
Young Mi Park
,
Anbok Lee
,
Ha Young Park
,
Yoo Jin Lee
,
Ji-Yeon Han
Postpartum Galactocele in Augmented Breast after Using Breast Pump Mimicking Breast Implant-Associated Anaplastic Large Cell Lymphoma: A Case Report.
Taehan Yongsang Uihakhoe chi
82 (6) (2021)
Gi Won Shin
,
Young Mi Park
,
Tae Hyun Kim
,
Anbok Lee
,
Ha Young Park
,
Hye Kyoung Yoon
,
Young Jin Heo
,
Jin Wook Baek
,
Yoo Jin Lee
Erratum: Bilateral Triple Negative Invasive Ductal Breast Carcinoma in a BRCA1 Mutation Carrier with Discrepant Pathologic Response to Neoadjuvant Chemotherapy.
Taehan Yongsang Uihakhoe chi
81 (3) (2020)
Anbok Lee
,
Byung-In Moon
,
Tae Hyun Kim
BRCA1/BRCA2 Pathogenic Variant Breast Cancer: Treatment and Prevention Strategies.
Annals of laboratory medicine
40 (2) (2020)
Gi Won Shin
,
Young Mi Park
,
Tae Hyun Kim
,
Anbok Lee
,
Ha Young Park
,
Hye Kyoung Yoon
,
Young Jin Heo
,
Jin Wook Baek
,
Yoo Jin Lee
Bilateral Triple Negative Invasive Ductal Breast Carcinoma in a BRCA1 Mutation Carrier with Discrepant Pathologic Response to Neoadjuvant Chemotherapy.
Taehan Yongsang Uihakhoe chi
81 (2) (2020)
Jiwon Park
,
Yumi Shin
,
Tae Hyun Kim
,
Dong-Hyun Kim
,
Anbok Lee
Plasma metabolites as possible biomarkers for diagnosis of breast cancer.
PloS one
14 (12) (2019)
Hee Yeon Kim
,
Tae Hyun Kim
,
Hye Kyoung Yoon
,
Anbok Lee
The Role of Neutrophil-lymphocyte Ratio and Platelet-lymphocyte Ratio in Predicting Neoadjuvant Chemotherapy Response in Breast Cancer.
Journal of breast cancer
22 (3) (2019)